Lee M. Jampol

Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema

John A. Wells, Adam R. Glassman, Allison R. Ayala et al. · Ophthalmology · 2016 · 982 citations · Full text

Diabetic Retinopathy, Ocular Disease, Ophthalmology +4

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy

Jeffrey G. Gross, Adam R. Glassman, Lee M. Jampol et al. · JAMA · 2015 · 743 citations

Development of Metastatic Disease After Enrollment in the COMS Trials for Treatment of Choroidal Melanoma

Marie Diener‐West, Sandra M. Reynolds, Donna J Agugliaro et al. · Archives of Ophthalmology · 2005 · 613 citations

Intravitreal Ranibizumab for Diabetic Macular Edema with Prompt versus Deferred Laser Treatment: 5-Year Randomized Trial Results

Michael J. Elman, Allison R. Ayala, Neil M. Bressler et al. · Ophthalmology · 2014 · 564 citations

Diabetic Retinopathy, Ocular Disease, Vitreous Body +5

Genetic variants near <i>TIMP3</i> and high-density lipoprotein–associated loci influence susceptibility to age-related macular degeneration

Wei Chen, Dwight Stambolian, Albert O. Edwards et al. · Proceedings of the National Academy of Sciences · 2010 · 511 citations · Full text